| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.22 | 3e-05 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.13 | 3e-05 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.19 | 6e-05 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |